i
CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide : Chicago, IL
-
12/21/17
-
[PDF-321.85 KB]
Details:
-
Corporate Authors:
-
Description:$710,102 Funding for AR Activities Fiscal Year 2017
Funding to local health departments:
$297,684 - RAPID DETECTION & RESPONSE to emerging drug-resistant germs is cri cal to contain the spread of these infec ons. With 2016 funding, Chicago collaborated with multisector partners to rapidly respond to a rare cluster of VIM-producing Pseudomonas. Chicago successfully detected the transmission, coordinated public health lab testing, identified ed infecction control gaps and made recommenda ons to further prevent spread.
$322,316 - HAI/AR PREVENTION works best when public health and healthcare facilities partner together to implement targeted, coordinated strategies to stop infections and improve antibiotic use. With 2016 funding, Chicago used social network analyses—a scientific method for idetifying how healthcare facilities are interconnected and share patients—to prioritize facili es for targeted prevention and infection control assessments to prevent the spread of healthcare associated infections.
$90,102 - FOOD SAFETY projects protect communities by rapidly idetifying drug-resistant foodborne bacteria to stop and solve outbreaks and improve prevention.In Fiscal Year 2018, Chicago will ramp up tes ng to include whole genome sequencing of all Listeria, Salmonella, Campylobacter and E. coli isolates and simultaneously monitor these isolates for resistance genes. States upload the sequence data into PulseNet for nationwide monitoring of outbreaks and trends. When outbreaks are detected, local CDC-supported epidemiologists inves gate the cases to stop spread.
Publication date from document properties.
Chicago-2017-CDC-AR-Investments.pdf
-
Subjects:
-
Series:
-
Document Type:
-
Genre:
-
Place as Subject:
-
Pages in Document:1 numbered page
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
